Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Immunotherapies for T Cell Lymphoma and Leukemia
Paola Ghione, Alison J. Moskowitz, Nadia E. K. De Paola, et al.
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 494-506
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 99
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Fabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1757-1757
Open Access | Times Cited: 73
Chimeric Antigen Receptors for T-Cell Malignancies
Lauren Scherer, Malcolm K. Brenner, Maksim Mamonkin
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 65
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Quercetin as a Novel Therapeutic Approach for Lymphoma
Saiedeh Razi Soofiyani, Kamran Hosseini, Haleh Forouhandeh, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 36
Cancer immunotherapy
Ruby Dhar, Ashikh Seethy, Sunil Kumar Singh, et al.
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 4, pp. 834-844
Open Access | Times Cited: 36
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy
Jingjing Ren, Xiaofeng Liao, Julia M. Lewis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Enteropathy-Associated T cell Lymphoma
Zakiah Al Somali, Mehdi Hamadani, Mohamed A. Kharfan‐Dabaja, et al.
Current Hematologic Malignancy Reports (2021) Vol. 16, Iss. 2, pp. 140-147
Closed Access | Times Cited: 29
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
Tobias Suske, Helena Sorger, Gabriele Manhart, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 3
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S. Imber, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 61, Iss. 14, pp. 3331-3341
Open Access | Times Cited: 25
Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas
Florencia Cayrol, Helena Sterle, María C. Díaz Flaqué, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 25
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia
Janisha Patel, Xueliang Gao, Haizhen Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7201-7201
Open Access | Times Cited: 7
The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
Zhaorui Liu, Xuesong Wu, Samuel Hwang, et al.
Annals of Dermatology (2021) Vol. 33, Iss. 6, pp. 487-487
Open Access | Times Cited: 16
Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies
Mathew G. Angelos, Ruchi P. Patel, Marco Ruella, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 2, pp. 171-186
Open Access | Times Cited: 5
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties
Ayse Meric Ovacik, Ji Li, M. Lemper, et al.
mAbs (2018) Vol. 11, Iss. 2, pp. 422-433
Open Access | Times Cited: 15
T-cell therapies for T-cell lymphoma
Keri Toner, Catherine M. Bollard, Hema Dave
Cytotherapy (2019) Vol. 21, Iss. 9, pp. 935-942
Closed Access | Times Cited: 14
Harnessing immunotherapy for pediatric T-cell malignancies
Caroline Diorio, David T. Teachey
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 4, pp. 361-371
Open Access | Times Cited: 14
Aging and immunotherapies: New horizons for the golden ages
Jamie A.G. Hamilton, Curtis J. Henry
Aging and Cancer (2020) Vol. 1, Iss. 1-4, pp. 30-44
Open Access | Times Cited: 14
Growth of T-cell lymphoma cells is inhibited by mPGES-1/PGE2 suppression via JAK/STAT, TGF-β/Smad3 and PI3K/AKT signal pathways
Yiqing Li, Meng Qiu, Boqi Li, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 7, pp. 2175-2184
Open Access | Times Cited: 6
Central Nervous System Involvement of Natural Killer and T Cell Neoplasms
Ashley Aaroe, Kathryn Nevel
Current Oncology Reports (2019) Vol. 21, Iss. 5
Closed Access | Times Cited: 7
Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?
Rita Assi, Huda Salman
Cells (2022) Vol. 11, Iss. 24, pp. 3971-3971
Open Access | Times Cited: 3
Modern immunotherapy using CAR-T cells in haemato-oncology and solid tumors
Anna Bogacz, Alicja Bukowska, Marta Bukowska, et al.
Acta Haematologica Polonica (2024)
Open Access
Immune Checkpoints and Their Inhibition in T-Cell Lymphomas
Jana Seňavová, Anežka Rajmonová, V. Herman, et al.
Folia Biologica (2024) Vol. 70, Iss. 3, pp. 123-151
Closed Access
Ears, Nose, and Throat in Leukemias and Lymphomas
Pinelopi Samara, Michail Athanasopoulos, Ioannis Athanasopoulos
Encyclopedia (2024) Vol. 4, Iss. 4, pp. 1891-1903
Open Access
STAT5 Gain-of-Function Variants Promote Precursor T-Cell Receptor Activation to Drive T-Cell Acute Lymphoblastic Leukemia
Tobias Suske, Helena Sorger, Frank Ruge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top